As of 4:03pm ET
| -0.62 / -1.47%|
The 31 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 45.13, with a high estimate of 54.90 and a low estimate of 34.89. The median estimate represents a +8.51% increase from the last price of 41.59.
The current consensus among 34 polled investment analysts is to Hold stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.